India  

"Sputnik V" "Dr Reddy"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 

Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer [Video]

Closing bell: Equity indices in positive terrain, Dr Reddy's top gainer

Equity benchmark indices traded higher in the afternoon session on September 16 while Asian stocks were flat ahead of the US Federal Reserve's view on the economy. The BSE S-P Sensex closed 259 points..

Credit: ANI     Duration: 01:21Published
Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News [Video]

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's..

Credit: Oneindia     Duration: 01:03Published

You Might Like


India trials for Russia's 'Sputnik-V' vaccine could start in next few weeks

Indian trials of the Sputnik-V vaccine candidate, being developed by Russia`s sovereign wealth fund, will enroll 1,000-2,000 participants and be conducted at multiple government and private hospitals..
DNA - Published Also reported by •IndiaTimes

The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?

How will the tie-up with Dr. Reddy’s Laboratories help India?
Hindu - Published

COVID-19 vaccine to be available in India by early 2021: Union Health Minister Harsh Vardhan

Meanwhile, Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of the world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds..
DNA - Published

COVID-19 vaccination to be available by 'start of next year': Harsh Vardhan

Union Health Minister Harsh Vardhan on Thursday said that the coronavirus vaccine will be made available in the country by the start of next year. The remarks come at a time when India is recording..
Mid-Day - Published

Russia, Dr Reddy’s tie up for Sputnik V trial

Russia’s sovereign wealth fund – Russian Direct Investment Fund (RDIF) — has partnered Hyderabad-based drug maker Dr Reddy’s Laboratories to cooperate on clinical trials and distribution of..
IndiaTimes - Published

Dr Reddy’s inks deal to distribute 100 mn doses of Sputnik V


Indian Express - Published

Russia inks pact to test, supply Sputnik V vaccine to India

Agreement with Dr. Reddy’s Laboratories doesn’t include its manufacture.
Hindu - Published

Russia confirms deal with Dr. Reddy's for COVID-19 vaccine 'Sputnik V' trials in India, to supply 100 million doses

Russia's sovereign wealth fund on Wednesday agreed to supply 100 million doses of world's first COVID-19 vaccine Sputnik-V to Indian drug company Dr Reddy's Laboratories as Moscow speeds up plans to..
DNA - Published

Russia to sell 100 million doses of Covid-19 vaccine to India

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against Covid-19 once it receives regulatory approval...
IndiaTimes - Published Also reported by •newKerala.comMid-Day